Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of KDT-3594 in Early Parkinson's Disease
NCT04867551Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- May 2021
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
A Phase 2 trial of matsupexole in Parkinson's disease (PD), sponsored by Kissei Pharmaceutical Co., Ltd.. Started May 2021; status: completed.
02
Drugs
matsupexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04867551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867551.